Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The evaluation of the efficacy of an intraportal infusion with Tacrolimus, at the time of
liver graft implantation, compared to a control group without immunosuppressive intraportal
infusion (Placebo: Saline solution 0.9%) with respect to the initial liver function measured
by the parameters of the liver function (LFP): AST (U/L), ALT (U/L), total Bilirubin (mg/dL)
and the coagulation factors: NT (%), PTT (s), INR.